The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
Shic F, Naples AJ, Barney EC, Chang SA, Li B, McAllister T, Kim M, Dommer KJ, Hasselmo S, Atyabi A, Wang Q, Helleman G, Levin AR, Seow H, Bernier R, Charwaska K, Dawson G, Dziura J, Faja S, Jeste SS, Johnson SP, Murias M, Nelson CA, Sabatos-DeVito M, Senturk D, Sugar CA, Webb SJ, McPartland JC. The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials. Molecular Autism 2022, 13: 15. PMID: 35313957, PMCID: PMC10124777, DOI: 10.1186/s13229-021-00482-2.Peer-Reviewed Original ResearchMeSH KeywordsAutism Spectrum DisorderAutistic DisorderBiomarkersChildEye MovementsEye-Tracking TechnologyHumansConceptsAutism spectrum disorderBiological motion preferenceSocial interactiveHuman faceMotion preferencesAutism symptom severityPragmatic communication skillsHigher verbal IQAttentional processesASD groupScene tasksVerbal IQTypical developmentSocial scenesSpectrum disorderOculomotor indicesReflex taskStandardized contextEye movementsCommunication skillsConstruct validitySymptom severityTaskPsychiatric conditionsSpecific interventions